Functionalized chitosan as nano-delivery platform for CRISPR-Cas9 in cancer treatment
CRISPR-Cas system permanently deletes any harmful gene-of-interest to combat cancer growth. Chitosan (CS) is a potential cancer therapeutic that mediates via PI3K/Akt/mTOR, MAPK and NF-kβ signaling pathway modulation. CS and its covalent derivatives have been designed as nanocarrier of CRISPR-Cas9 a...
שמור ב:
| Principais autores: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
KeAi Communications Co., Ltd.
2025-06-01
|
| סדרה: | Asian Journal of Pharmaceutical Sciences |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S1818087625000261 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|